Xcout Intel
PhaseV competitors & alternatives
The 12 closest competitors and alternatives to PhaseV among biotech companies — ranked by similarity to what PhaseV actually does, not by market-cap band.
Subscribe to see PhaseV’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About PhaseV
PhaseV uses causal machine learning and generative AI to optimize clinical trial designs and improve drug development processes.
PhaseV at a glance
PhaseV is a biotech company headquartered in Israel, founded in 2023. It has raised at least $65M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $50M in May 2025. Xcout tracks 3 named people at PhaseV, including Raviv Pryluk, PhD (CEO, Co-Founder). Xcout recorded 17 job postings from PhaseV in the last 90 days.
PhaseV leadership
- Raviv Pryluk, PhDCEO, Co-Founder
- Elad Berkman, MScCTO, Co-Founder
- Dan Goldstaub, PhDScientific Co-Founder
PhaseV funding rounds
At least $65M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $50M | 2 named | |
| — | $15M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at PhaseV
Xcout recorded 17 job postings from PhaseV in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see PhaseV's hiring signals →
Top 12 PhaseV competitors
Ranked by semantic similarity — how close each company is to PhaseV by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Biotechnology
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Healthcare
Aira Health is a biotechnology research company based in Boston, Massachusetts, that provides a unified AI platform for clinical trial design and protocol development.
Healthtech
ArcaScience is a pharmaceutical artificial intelligence company headquartered in Paris, France, that develops an advanced benefit-risk decision engine and drug safety platforms.
Biotechnology
Biotx.ai applies large-scale Mendelian randomization and causal AI to human genetics data to map causal relationships between genes and biological outcomes. The company generates datasets and AI models that assist researchers and organizations in discovering novel drug targets and improving clinical trial design across various therapeutic areas.
Similar biotech company
Formation Bio is a U.S.-based technology and drug-development company, formerly known as TrialSpark, that uses AI and software to help pharmaceutical companies develop medicines more efficiently. It serves biopharmaceutical partners by supporting clinical-trial operations and other parts of the drug-development process.
Biotechnology
WittGen Inc. provides a virtual cell-to-patient profiling technology powered by single-cell generative AI for clinical leaders and biopharmaceutical researchers. The company's platform transforms archived bulk RNA samples and pathological image data into regulator-ready patient stratification insights and cellular-level biomarkers to de-risk clinical trials and accelerate oncology drug development.
Similar biotech company
BenevolentAI provides an artificial intelligence platform and life science intelligence tools designed to assist scientists and pharmaceutical executives in drug discovery and research and development decision-making. The company leverages proprietary technology and machine learning to analyze biological data and support complex R&D processes.
Similar biotech company
VeriSIM Life provides an AI-driven drug discovery and development platform called BIOiSIM that uses mechanistic and quantitative methods to predict patient outcomes and de-risk clinical trials. The company serves pharmaceutical companies, biotechnology firms, and academic research institutions by generating actionable insights for drug repurposing, safety-toxicity profiles, and efficacy predictions.
Biotechnology
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Life Sciences
Ryght AI is an artificial intelligence company headquartered in Southern California that provides an AI-powered platform to rapidly analyze clinical trial protocols and connect researchers with sites worldwide.
Biotechnology
Shift Bioscience is a biotechnology research company based in Cambridge, United Kingdom, that employs generative AI virtual cell models to understand gene activation and cellular reprogramming.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of PhaseV and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for PhaseVand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →